New York Gov. Kathy Hochul (D-N.Y.) on Wednesday urged parents in the state to prepare for the colder weather months and remask their toddlers to protect them from respiratory syncytial virus (RSV) infections.
RSV is a common seasonal flu caused by influenza viruses that infects the lungs and breathing passages. Most people, including infants, develop only mild cold-like symptoms such as a runny nose, coughing, decreased appetite, and fever, and typically recover within a week. In some rare cases, RSV can cause severe symptoms and even be life-threatening, especially for infants and children younger than five.
The Democrat governor stated RSV “does hit younger children,” arguing the practice of wearing masks has been normalized by now and children are “socialized to the idea” anyway.
“There’s a lot of cute masks out there, I’ve seen a lot of them,” Hochul said. “So, that’s something I’m encouraging all parents to consider for their children right now.”
Hochul failed to mention that since the COVID-19 pandemic and the government’s enforcement of mask mandates, numerous medical professionals and studies have indicated that masking children does more harm than good.
Moreover, besides repercussions to children’s brain development when they and others around them are wearing masks, children often don’t wear masks properly, so the already-limited benefit is lowered even further.
More Details on RSV
RSV can be severe in infants and older adults and is the most common cause of bronchiolitis (which causes inflammation and congestion in the small airways in the lung) and pneumonia (infection and inflammation of the lungs) in children under one in the United States.Almost all children will have had an RSV infection by age 2, health officials say, and an estimated 58,000 children younger than 5 years old are hospitalized due to RSV infections each year.
However, very young infants, children with chronic lung disease or congenital heart disease, and those with weakened immune systems are at the greatest risk of severe illness from the virus.
There is no vaccine against RSV, although Pfizer Inc. is developing RSVpreF for adults. In the meantime, Hochul urged New Yorkers during Tuesday’s news conference to get up to date on their seasonal flu, COVID-19, and newly authorized bivalent booster shots, saying it’s the “best defense against respiratory viruses.”